Judges Scientific plc
JSCIF
$87.59
$3.093.66%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.26% | 14.68% | 0.34% | 0.03% | -0.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.26% | 14.68% | 0.34% | 0.03% | -0.04% |
| Cost of Revenue | 22.50% | 14.90% | 4.20% | 4.50% | -8.02% |
| Gross Profit | 21.28% | 13.76% | -0.25% | -0.56% | 57.22% |
| SG&A Expenses | -- | -- | 9.32% | 8.99% | -- |
| Depreciation & Amortization | 23.54% | 15.88% | -7.61% | -7.90% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.35% | 14.76% | 7.54% | 7.20% | 0.03% |
| Operating Income | 21.63% | 14.09% | -29.84% | -30.05% | -0.56% |
| Income Before Tax | 20.50% | 13.03% | -28.62% | -28.85% | 94.84% |
| Income Tax Expenses | 5.90% | -0.67% | -57.55% | -57.68% | -16.02% |
| Earnings from Continuing Operations | 25.60% | 17.80% | -22.97% | -23.21% | 261.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -217.59% | -197.95% | -54.67% | -54.19% | 49.60% |
| Net Income | 21.02% | 13.51% | -24.80% | -25.03% | 323.26% |
| EBIT | 21.63% | 14.09% | -29.84% | -30.05% | -0.56% |
| EBITDA | 24.38% | 16.67% | -21.22% | -21.46% | -11.82% |
| EPS Basic | 20.75% | 13.24% | -25.07% | -25.29% | 309.43% |
| Normalized Basic EPS | 19.75% | 12.32% | -49.51% | -49.67% | 97.67% |
| EPS Diluted | 20.84% | 13.34% | -25.13% | -25.37% | 310.23% |
| Normalized Diluted EPS | 19.88% | 12.44% | -49.56% | -49.72% | 97.63% |
| Average Basic Shares Outstanding | 0.23% | 0.23% | 0.36% | 0.36% | 3.40% |
| Average Diluted Shares Outstanding | 0.14% | 0.14% | 0.46% | 0.46% | 3.38% |
| Dividend Per Share | 16.60% | 9.35% | 13.43% | 13.05% | 10.83% |
| Payout Ratio | -- | -- | 0.56% | 0.56% | -- |